Results 251 to 260 of about 74,627 (275)
Some of the next articles are maybe not open access.
Management of malignant pleural effusions
Current Opinion in Internal Medicine, 2005Although malignant pleural effusions are a common medical problem, research into their optimal management remains sparse. The aim of this review is to summarise recent developments in this area.Talc remains the most efficacious pleurodesis agent.
Bennett, R, Maskell, NA
openaire +3 more sources
2004
The presence of pleural effusions is a common clinical problem in patients with neoplastic disease. At the time of diagnosis, approximately 15% of lung cancer patients have a pleural effusion (Naito et al. 1997).Twenty to 50% of patients with advanced or disseminated lung cancer develop a pleural effusion during the course of the ir disease (Emerson et
van Schil, Paul, Germonpré, Paul
openaire +3 more sources
The presence of pleural effusions is a common clinical problem in patients with neoplastic disease. At the time of diagnosis, approximately 15% of lung cancer patients have a pleural effusion (Naito et al. 1997).Twenty to 50% of patients with advanced or disseminated lung cancer develop a pleural effusion during the course of the ir disease (Emerson et
van Schil, Paul, Germonpré, Paul
openaire +3 more sources
Fatigue and malignant pleural effusions
BMJ Supportive & Palliative Care, 2021Dear Editors We completely agree with Twose et al 1 that until now the primary focus in both clinical practice and trials has been on interventions in malignant pleural effusions (MPEs), tailored to mitigating breathlessness and preventing admissions, with little consideration of other factors potentially of greater priority to the patient.
Avinash Aujayeb, Donna Wakefield
openaire +3 more sources
Surgical Clinics of North America, 2002
The management of pleural effusions and, in particular, recurrent MPE require an accurate assessment of the characteristics of the pleural fluid and the relief of the patient's symptoms. Although a common problem, treatment of pleural effusions and MPE is highly variable.
openaire +3 more sources
The management of pleural effusions and, in particular, recurrent MPE require an accurate assessment of the characteristics of the pleural fluid and the relief of the patient's symptoms. Although a common problem, treatment of pleural effusions and MPE is highly variable.
openaire +3 more sources
Management of Malignant Pleural Effusions
Seminars in Respiratory and Critical Care Medicine, 2008Malignant pleural effusions (MPEs) are commonly seen as complications of advanced malignancy, especially in lung cancer and breast cancer. The management will depend on the performance status of the patient, severity of the symptoms, and the primary tumor's response to systemic therapy.
Jeffrey Pollak, Marcelo Spector
openaire +3 more sources
Annals of Internal Medicine, 1978
Excerpt To the editor: To the excellent review of malignant pleural effusion by Leff, Hopewell, and Costello (Ann Intern Med88:532-537, 1978) I wish to add these practical clinical points. 1.
openaire +3 more sources
Excerpt To the editor: To the excellent review of malignant pleural effusion by Leff, Hopewell, and Costello (Ann Intern Med88:532-537, 1978) I wish to add these practical clinical points. 1.
openaire +3 more sources
Management of malignant pleural effusion
Journal of Surgical Oncology, 1978AbstractA pleural effusion is a frequent complication of malignant disease. Essential to the care of oncology patients is a fundamental knowledge of the pathophysiology and treatment of such effusions. This article discusses the current thoughts concerning the occurrence of malignant effusions, outlines the current available methods and agents employed
John M. Bennett +3 more
openaire +3 more sources
Management of Malignant Pleural Effusions
Chest, 1993Malignant pleural effusions (MPEs) are a common complication of advanced malignancies, particularly lung and breast cancer. They are caused by a variety of mechanisms including tumor obstruction of lymphatic flow, spread of malignant cells via the systemic circulation, and tumor invasion of the pulmonary arterioles.
openaire +3 more sources
Treatment of malignant pleural effusions
Current Opinion in Pulmonary Medicine, 1999Malignant pleural effusions are common in cancer patients with advanced disease. These patients usually present with chest pain, cough, and progressive shortness of breath, all of which may cause significant impairment in quality of life. Therapeutic options include systemic treatment; thoracentesis; or, most commonly, tube drainage and sclerotherapy ...
Edward F. Patz, Jeremy J. Erasmus
openaire +3 more sources
Treatment of Malignant Pleural Effusion
Chest, 1985Two hundred consecutive patients with malignant pleural effusion were reviewed. The pathologic etiology of malignant pleurisy was: primary lung cancer in 123 cases; five, mesothelioma; and 72 cases secondary to metastatic tumors. Adenocarcinoma of the lung and mammary cancer were the most frequent tumors causing malignant pleural effusion.
Yoshiki Takeuchi +4 more
openaire +2 more sources